Robert Bresalier

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi request reprint Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation
    Shumei Song
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Gastroenterology 129:1581-91. 2005
  2. pmc Early detection of and screening for colorectal neoplasia
    Robert S Bresalier
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Gut Liver 3:69-80. 2009
  3. ncbi request reprint Barrett's Metaplasia: defining the problem
    Robert Bresalier
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Semin Oncol 32:21-4. 2005
  4. ncbi request reprint Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Robert S Bresalier
    Department of Gastrointestinal Medicine and Nutrition, University of Texas M D Anderson Cancer Center, Houston 77030 4009, USA
    N Engl J Med 352:1092-102. 2005
  5. doi request reprint Management of high-risk colonoscopy patients
    Robert S Bresalier
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1466, Houston, TX 77030 4009, USA
    Gastrointest Endosc Clin N Am 20:629-40. 2010
  6. ncbi request reprint Management of Barrett's esophagus: cases and questions
    Robert Bresalier
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Semin Oncol 32:S2-5. 2005
  7. ncbi request reprint A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer
    Robert S Bresalier
    Department of Gastrointestinal Medicine and Nutrition, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 436, Houston, Texas 77030, USA
    Gastroenterology 127:741-8. 2004
  8. ncbi request reprint Chemoprevention of colorectal cancer: why all the confusion?
    Robert S Bresalier
    The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Gastroenterol 24:48-50. 2008
  9. doi request reprint Barrett's Esophagus and esophageal adenocarcinoma
    Robert S Bresalier
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Annu Rev Med 60:221-31. 2009
  10. ncbi request reprint Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging
    Jeremy J Erasmus
    Department of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Thorac Oncol 1:478-86. 2006

Research Grants

  1. MUCIN GLYCOPROTEINS IN COLON CANCER METASTASIS
    Robert S Bresalier; Fiscal Year: 2010
  2. MUCIN GLYCOPROTEINS IN COLON CANCER METASTASIS
    Robert Bresalier; Fiscal Year: 2007
  3. MUCIN GLYCOPROTEINS IN COLON CANCER METASTASIS
    Robert Bresalier; Fiscal Year: 2002

Detail Information

Publications49

  1. ncbi request reprint Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation
    Shumei Song
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Gastroenterology 129:1581-91. 2005
    ..Galectin-3 modulates expression of MUC2 protein, but the specific regulatory mechanisms are unknown. This study sought to determine how galectin-3 increases MUC2 expression...
  2. pmc Early detection of and screening for colorectal neoplasia
    Robert S Bresalier
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Gut Liver 3:69-80. 2009
    ..The guidelines for screening for colorectal neoplasia have recently been substantially revised by several organizations based on developing technologies and a growing body of data on the efficacy of CRC screening...
  3. ncbi request reprint Barrett's Metaplasia: defining the problem
    Robert Bresalier
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Semin Oncol 32:21-4. 2005
    ..In this article, the relationship between BE and gastroesophageal reflux disease, risk for adenocarcinoma, and prospects for molecular diagnosis are discussed...
  4. ncbi request reprint Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Robert S Bresalier
    Department of Gastrointestinal Medicine and Nutrition, University of Texas M D Anderson Cancer Center, Houston 77030 4009, USA
    N Engl J Med 352:1092-102. 2005
    ....
  5. doi request reprint Management of high-risk colonoscopy patients
    Robert S Bresalier
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1466, Houston, TX 77030 4009, USA
    Gastrointest Endosc Clin N Am 20:629-40. 2010
    ..Proper risk stratification, understanding the natural history of each disease, proper patient counseling, and optimal techniques all help define quality colonoscopy in high-risk groups...
  6. ncbi request reprint Management of Barrett's esophagus: cases and questions
    Robert Bresalier
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Semin Oncol 32:S2-5. 2005
    ..More prospective data on disease progression and an improved knowledge of risk factors are needed to help define optimal management strategies...
  7. ncbi request reprint A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer
    Robert S Bresalier
    Department of Gastrointestinal Medicine and Nutrition, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 436, Houston, Texas 77030, USA
    Gastroenterology 127:741-8. 2004
    ..To determine whether circulating galectin-3 ligands are related to the presence of colon cancer, we sought to identify and quantify ligands in serum that bind to galectin-3...
  8. ncbi request reprint Chemoprevention of colorectal cancer: why all the confusion?
    Robert S Bresalier
    The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Gastroenterol 24:48-50. 2008
    ..Findings from prospective randomized trials often conflict with those of observational studies. This review discusses some of the possible reasons based on recent clinical trials...
  9. doi request reprint Barrett's Esophagus and esophageal adenocarcinoma
    Robert S Bresalier
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Annu Rev Med 60:221-31. 2009
    ....
  10. ncbi request reprint Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging
    Jeremy J Erasmus
    Department of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Thorac Oncol 1:478-86. 2006
    ..We evaluated the use of integrated computed tomography (CT)-PET among patients with esophageal cancer being considered for resection after CRT...
  11. ncbi request reprint Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia
    Sharmila Anandasabapathy
    Department of Gastroenterology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 109:668-74. 2007
    ..Identifying simple, reliable, clinical, and endoscopic predictors of high-grade dysplasia and adenocarcinoma would be helpful for risk stratification in screening and surveillance programs...
  12. ncbi request reprint Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma
    S Chris Malaisrie
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Tex 77030, USA
    J Thorac Cardiovasc Surg 131:65-72. 2006
    ..We reviewed our experience with preoperative chemoradiotherapy in patients with adenocarcinoma of the distal esophagus and pretreatment endoscopic ultrasonography-identified celiac adenopathy...
  13. ncbi request reprint Mucins and mucin binding proteins in colorectal cancer
    James C Byrd
    The Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 436 Houston, TX 77030, USA
    Cancer Metastasis Rev 23:77-99. 2004
    ..Interference of the binding of selectins and galectin-3 to mucin may show therapeutic or preventative promise for colon cancer...
  14. ncbi request reprint Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer
    Mary Ann Weiser
    Department of General Internal Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Med Sci 330:11-8. 2005
    ..For some patients, diagnostic options may be limited either because of tumor location, underlying comorbid conditions, or lack of access to care...
  15. ncbi request reprint Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis
    Julie G Izzo
    Department of Experimental Therapeutics, University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Semin Oncol 32:S11-5. 2005
    ....
  16. ncbi request reprint Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation
    Rajyalakshmi Luthra
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77054, USA
    J Clin Oncol 24:259-67. 2006
    ..Currently, however, there are no tools to help select optimum therapy. We hypothesized that gene expression profiling could provide clues and biomarkers for selection of therapy...
  17. pmc Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression
    Shumei Song
    Department of Gastroenterology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Clin Cancer Res 15:622-31. 2009
    ..This study was designed to determine the effects of Poly E on the growth of human Barrett's and aerodigestive adenocarcinoma cells and the mechanisms involved in growth regulation by this agent...
  18. pmc Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity
    Shumei Song
    Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer Res 69:1343-9. 2009
    ....
  19. ncbi request reprint Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer
    Stephen G Swisher
    Department of Thoracic Surgery, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Ann Thorac Surg 78:1152-60; discussion 1152-60. 2004
    ....
  20. pmc COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma
    Shumei Song
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Gut 56:1512-21. 2007
    ..We analysed the molecular mechanisms that govern bile acid-mediated expression of COX-2 in Barrett's oesophagus and oesophageal adenocarcinoma (OA)...
  21. doi request reprint Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center
    Brian R Weston
    Department of Gastroenterology, Hepatology and Nutrition, Unit 1466, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 1402, USA
    Cancer 116:1454-61. 2010
    ..The purpose of this study was to assess the ability of PET-CT to detect colonic pathology and to determine the significance of ((18)F)2-fluoro-2-deoxyglucose ((18)F-FDG) activity noted incidentally in the colon on PET-CT...
  22. ncbi request reprint The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk
    Robert S Bresalier
    Department of Gastrointestinal, Medicine and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Am J Cardiol 96:1589-604. 2005
  23. ncbi request reprint Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy
    Pooja R Rohatgi
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:552-8. 2006
    ..The current study tested the hypothesis that the clinical outcome of patients with localized esophageal carcinoma after preoperative chemoradiotherapy (CTRT) depends on histology...
  24. ncbi request reprint Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells
    Nachman Mazurek
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Biol Chem 282:21337-48. 2007
    ..These findings suggest a pivotal role for P-GAL3 in promoting TRAIL sensitivity through activation of a nonclassic apoptotic pathway and identify P-GAL3 as a novel regulator of PTEN...
  25. ncbi request reprint Preface: colorectal cancer
    Robert S Bresalier
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer Metastasis Rev 23:7-9. 2004
  26. ncbi request reprint Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma
    David Hong
    Department of GI Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:1620-6. 2005
    ..The authors tested the hypothesis that, in this setting, the number of PET abnormalities (NPA) would correlate with OS and DFS...
  27. ncbi request reprint Bile acids induce MUC2 overexpression in human colon carcinoma cells
    Shumei Song
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 103:1606-14. 2005
    ..Bile acids have been linked to colorectal carcinogenesis and mucin secretion, but their effects on mucin gene expression in human colon carcinoma cells is unknown..
  28. ncbi request reprint Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes
    Nachman Mazurek
    Department of Gastrointestinal Medicine and Nutrition, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Res 65:10767-75. 2005
    ..These data show the functional diversity of galectin-3 and suggest that phosphorylation of the protein is necessary for regulation (directly or indirectly) of unique sets of genes that play a role in malignant transformation...
  29. ncbi request reprint Dysplasia in Barrett esophagus
    Christopher D Lao
    Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Cancer 100:1622-7. 2004
    ..The objective of the current study was to more accurately determine the prevalence of dysplasia among individuals with Barrett esophagus who would be available for enrollment in a chemoprevention trial...
  30. ncbi request reprint Folic acid for the prevention of colorectal adenomas: a randomized clinical trial
    Bernard F Cole
    Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH, USA
    JAMA 297:2351-9. 2007
    ..Laboratory and epidemiological data suggest that folic acid may have an antineoplastic effect in the large intestine...
  31. ncbi request reprint Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy
    Paul F Pinsky
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7346, USA
    Clin Gastroenterol Hepatol 1:103-10. 2003
    ..The relationship between distal and proximal colonic findings is uncertain. Thus, there is no consensus on which findings on screening flexible sigmoidoscopy should trigger colonoscopy...
  32. ncbi request reprint Alternative splicing of the human MUC2 gene
    Lawrence R Sternberg
    Gastrointestinal Cancer Research Laboratory, Henry Ford Health Sciences Center, 2799 West Grand Blvd, Detroit, MI 48202, USA
    Arch Biochem Biophys 421:21-33. 2004
    ..The presence of MUC2.1 mucin may help us to explain previous conflicting reports that have attempted to correlate the relative abundance of MUC2 protein and/or mRNA with the biological behavior of colon cancer cells...
  33. ncbi request reprint Results of repeat sigmoidoscopy 3 years after a negative examination
    Robert E Schoen
    Department of Medicine, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA
    JAMA 290:41-8. 2003
    ..The necessary frequency of endoscopic colorectal cancer screening after a negative examination is uncertain...
  34. ncbi request reprint A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas
    John A Baron
    Department of Medicine, The Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire, USA
    Gastroenterology 131:1674-82. 2006
    ..We conducted a randomized, placebo-controlled, double-blind trial to assess whether use of the selective COX-2 inhibitor rofecoxib would reduce the risk of colorectal adenomas...
  35. ncbi request reprint Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward
    Gary J Kelloff
    National Cancer Institute, Bethesda, Maryland 20852, USA
    Clin Cancer Res 12:3661-97. 2006
    ....
  36. ncbi request reprint Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer
    Steven P Dudas
    Gastrointestinal Cancer Research Laboratory, Henry Ford Health Sciences Center, Detroit, Michigan, USA
    Gastroenterology 123:817-26. 2002
    ..The current study was designed to investigate the relationship between galectin-3 production and MUC2 mucin synthesis by human colon cancer cells...
  37. ncbi request reprint Hemochromatosis gene mutations and distal adenomatous colorectal polyps
    Katherine A McGlynn
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, EPS 7060, 6120 Executive Boulevard, Rockville, MD 20852 7234, USA
    Cancer Epidemiol Biomarkers Prev 14:158-63. 2005
    ..These results do not support a relationship between HFE heterozygosity and risk of advanced distal adenoma...
  38. ncbi request reprint CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma
    Lifang Hou
    Department of Human and Health Services, Division of Cancer Epidemiology and Genetics, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7240, USA
    Carcinogenesis 26:1122-8. 2005
    ..002). In summary, joint carriage of CYP1A1 Val(462) and NQO1 Ser(187) alleles, particularly in smokers, was related to colorectal adenoma risk, with a propensity for formation of multiple lesions...
  39. ncbi request reprint Colorectal cancer in patients under close colonoscopic surveillance
    Douglas J Robertson
    Section of Gastroenterology, VA Medical Center, White River Junction, Vermont 05009, USA
    Gastroenterology 129:34-41. 2005
    ..We determined the incidence of CRC in patients under colonoscopic surveillance and examined the circumstances and risk factors for CRC and adenoma with high-grade dysplasia...
  40. ncbi request reprint Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa
    Peter R Holt
    Department of Medicine, St Luke s Roosevelt Hospital Center, Columbia University, New York, New York, USA
    Cancer 106:287-96. 2006
    ..Biologic changes that may occur in colorectal adenomas after chemopreventive regimens have not been reported...
  41. ncbi request reprint Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma
    L Beth Dixon
    Department of Nutrition, Food Studies, and Public Health, New York University, New York City, NY 10012, USA
    J Nutr 137:2443-50. 2007
    ..lt;or=2 = 0.74, 95% CI = 0.55-0.99; P-trend = 0.08). Following the current U.S. dietary recommendations or a Mediterranean dietary pattern is associated with reduced risk of colorectal adenoma, especially in men...
  42. ncbi request reprint Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Joel L Weissfeld
    University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA
    Cancer 94:2569-76. 2002
    ..In the current prospective study, the authors used adherence to repeat testing to assess the acceptability of screening flexible sigmoidoscopy...
  43. pmc Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs
    Yukinori Takenaka
    Tumor Progression and Metastasis Program, Karmanos Cancer Institute, Detroit, Michigan 48201, USA
    Mol Cell Biol 24:4395-406. 2004
    ..These results suggest that Ser(6) phosphoryaltion acts as a molecular switch for its cellular translocation from the nucleus to the cytoplasm and, as a result, regulates the antiapoptotic activity of Gal-3...
  44. ncbi request reprint Chemoprevention of intestinal polyposis by COX-2 inhibition: from mouse to man
    Robert S Bresalier
    Gastroenterology 122:234-6. 2002
  45. ncbi request reprint Calcium intake and colorectal adenoma in a US colorectal cancer early detection program
    Ulrike Peters
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Am J Clin Nutr 80:1358-65. 2004
    ..Calcium can reduce the risk of colorectal tumors by binding secondary bile and fatty acids, which leads to antiproliferative effects in the bowel, or by acting directly on the colonic epithelium, which affects differentiation and apoptosis...
  46. ncbi request reprint Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story)
    Robert S Bresalier
    Curr Opin Gastroenterol 23:44-7. 2007
    ..Colorectal cancer is prevalent, deadly and expensive to treat. Chemoprevention provides an opportunity to prevent colorectal cancer through prevention of precursor adenomas...
  47. ncbi request reprint Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk
    Wen Yi Huang
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, EPS 8113, MSC 7240, Bethesda, Maryland 20892, USA
    Cancer Epidemiol Biomarkers Prev 15:306-11. 2006
    ....
  48. ncbi request reprint Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial
    Joel L Weissfeld
    University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
    J Natl Cancer Inst 97:989-97. 2005
    ..Here we report findings from the baseline screening flexible sigmoidoscopy examination...
  49. ncbi request reprint Intestinal mucin and colorectal cancer: it's not just goo
    Robert S Bresalier
    Gastroenterology 123:648-9. 2002

Research Grants13

  1. MUCIN GLYCOPROTEINS IN COLON CANCER METASTASIS
    Robert S Bresalier; Fiscal Year: 2010
    ..3) Determine the functional mechanism(s) by which galectin-3 modifies expression of MUC2 in colon cancer cells. ..
  2. MUCIN GLYCOPROTEINS IN COLON CANCER METASTASIS
    Robert Bresalier; Fiscal Year: 2007
    ..3) Determine the functional mechanism(s) by which galectin-3 modifies expression of MUC2 in colon cancer cells. ..
  3. MUCIN GLYCOPROTEINS IN COLON CANCER METASTASIS
    Robert Bresalier; Fiscal Year: 2002
    ..Further understanding of the roles of mucins and galectin-3 in colon cancer metastasis may make it possible to design specific diagnostic and therapeutic strategies to alter the course of metastatic disease. ..